210 related articles for article (PubMed ID: 33554686)
21. Clear cell sarcoma: state-of-the art and perspectives.
Wetterwald L; Riggi N; Kyriazoglou A; Dei Tos G; Dei Tos A; Digklia A
Expert Rev Anticancer Ther; 2023 Mar; 23(3):235-242. PubMed ID: 36811446
[TBL] [Abstract][Full Text] [Related]
22. Heterologous and rare homologous sarcomas of the uterine corpus: a clinicopathologic review.
Fadare O
Adv Anat Pathol; 2011 Jan; 18(1):60-74. PubMed ID: 21169739
[TBL] [Abstract][Full Text] [Related]
23. Pharmacotherapeutic strategies for epithelioid sarcoma: are we any closer to a non-surgical cure?
Meissner M; Napolitano A; Thway K; Huang P; Jones RL
Expert Opin Pharmacother; 2023; 24(12):1395-1401. PubMed ID: 37326105
[TBL] [Abstract][Full Text] [Related]
24. Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: an exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG).
Sleijfer S; Ouali M; van Glabbeke M; Krarup-Hansen A; Rodenhuis S; Le Cesne A; Hogendoorn PC; Verweij J; Blay JY
Eur J Cancer; 2010 Jan; 46(1):72-83. PubMed ID: 19853437
[TBL] [Abstract][Full Text] [Related]
25. Soft-tissue sarcoma in adults: An update on the current state of histiotype-specific management in an era of personalized medicine.
Gamboa AC; Gronchi A; Cardona K
CA Cancer J Clin; 2020 May; 70(3):200-229. PubMed ID: 32275330
[TBL] [Abstract][Full Text] [Related]
26. Targeted therapy and promising novel agents for the treatment of advanced soft tissue sarcomas.
Mohindra N; Agulnik M
Expert Opin Investig Drugs; 2015; 24(11):1409-18. PubMed ID: 26289790
[TBL] [Abstract][Full Text] [Related]
27. Appraising the current role of chemotherapy for the treatment of sarcoma.
D'Adamo DR
Semin Oncol; 2011 Oct; 38 Suppl 3():S19-29. PubMed ID: 22055968
[TBL] [Abstract][Full Text] [Related]
28. First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials.
Young RJ; Natukunda A; Litière S; Woll PJ; Wardelmann E; van der Graaf WT
Eur J Cancer; 2014 Dec; 50(18):3178-86. PubMed ID: 25459395
[TBL] [Abstract][Full Text] [Related]
29. Sarcomas of the Breast with a Spotlight on Angiosarcoma and Cystosarcoma Phyllodes.
Thornton K
Surg Oncol Clin N Am; 2016 Oct; 25(4):713-20. PubMed ID: 27591494
[TBL] [Abstract][Full Text] [Related]
30. Clinical practice guidelines for the diagnosis and treatment of patients with soft tissue sarcoma by the Spanish group for research in sarcomas (GEIS).
Garcia del Muro X; de Alava E; Artigas V; Bague S; Braña A; Cubedo R; Cruz J; Mulet-Margalef N; Narvaez JA; Martinez Tirado O; Valverde C; Verges R; Viñals J; Martin-Broto J;
Cancer Chemother Pharmacol; 2016 Jan; 77(1):133-46. PubMed ID: 26563256
[TBL] [Abstract][Full Text] [Related]
31. Soft tissue tumors of the trunk: management of local disease in the breast and chest and abdominal walls.
Wilder F; D'Angelo S; Crago AM
J Surg Oncol; 2015 Apr; 111(5):546-52. PubMed ID: 25418423
[TBL] [Abstract][Full Text] [Related]
32. Sarcoma.
Skubitz KM; D'Adamo DR
Mayo Clin Proc; 2007 Nov; 82(11):1409-32. PubMed ID: 17976362
[TBL] [Abstract][Full Text] [Related]
33. [Incidence rate, epidemiology of sarcoma and molecular biology. Preliminary results from EMS study in the Rhône-Alpes region].
Ducimetière F; Lurkin A; Ranchère-Vince D; Decouvelaere AV; Isaac S; Claret-Tournier C; Suignard Y; Salameire D; Cellier D; Alberti L; Bringuier PP; Blay JY; Ray-Coquard I
Bull Cancer; 2010 Jun; 97(6):629-41. PubMed ID: 20504759
[TBL] [Abstract][Full Text] [Related]
34. Next frontiers in systemic therapy for soft tissue sarcoma.
Yen CC; Chen TW
Chin Clin Oncol; 2018 Aug; 7(4):43. PubMed ID: 30173533
[TBL] [Abstract][Full Text] [Related]
35. Uncommon and peculiar soft tissue sarcomas: Multidisciplinary review and practical recommendations. Spanish Group for Sarcoma research (GEIS -GROUP). Part II.
Martínez-Trufero J; Cruz Jurado J; Hernández-León CN; Correa R; Asencio JM; Bernabeu D; Alvarez R; Hindi N; Mata C; Marquina G; Martínez V; Redondo A; Floría LJ; Gómez-Mateo MC; Lavernia J; Sebio A; Garcia Del Muro X; Martin-Broto J; Valverde-Morales C
Cancer Treat Rev; 2021 Sep; 99():102260. PubMed ID: 34340159
[TBL] [Abstract][Full Text] [Related]
36. Immune checkpoint inhibitors in treatment of soft-tissue sarcoma: A systematic review and meta-analysis.
Saerens M; Brusselaers N; Rottey S; Decruyenaere A; Creytens D; Lapeire L
Eur J Cancer; 2021 Jul; 152():165-182. PubMed ID: 34107450
[TBL] [Abstract][Full Text] [Related]
37. Pharmacotherapy for pediatric soft-tissue sarcomas.
Casanova M; Ferrari A
Expert Opin Pharmacother; 2011 Mar; 12(4):517-31. PubMed ID: 21306288
[TBL] [Abstract][Full Text] [Related]
38. Role of chemotherapy in patients with soft tissue sarcomas.
Maki RG
Expert Rev Anticancer Ther; 2004 Apr; 4(2):229-36. PubMed ID: 15056053
[TBL] [Abstract][Full Text] [Related]
39. A precision medicine approach in sarcoma: identification of patients who may benefit from early use of pazopanib.
Alavi SN; Florou V; Tinoco G; Trent JC; Wilky BA
Discov Med; 2018 Mar; 25(137):131-144. PubMed ID: 29641974
[TBL] [Abstract][Full Text] [Related]
40. Selection of Patients With Localized Extremity Soft Tissue Sarcoma for Treatment With Perioperative Chemotherapy.
Charlson J
Curr Treat Options Oncol; 2018 Oct; 19(12):65. PubMed ID: 30361919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
